Tourette Syndrome Is not Caused by Mutations in the Central Cannabinoid Receptor (CNR1) Gene

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 127 B, Issue 1, 2004, Pages 97-103

  Gadzicki, Dorothea ^a   Müller Vahl, Kirsten R ^a   Heller, Daniela ^a   Ossege, Sebastian ^a   Nöthen, Markus M ^b   Hebebrand, Johannes ^c   Stuhrmann, Manfred ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Association; Candidate gene; Polymorphism; RNA analysis; Segregation analysis

Indexed keywords

CANNABINOID 1 RECEPTOR; DRONABINOL; RNA; VALINE;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CODON; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GILLES DE LA TOURETTE SYNDROME; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; INHERITANCE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TIC;

CANNABIS SATIVA;

EID: 2142754520     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20159     Document Type: Article

References (28)

1. Barinaga M. 2001. Neurobiology: How cannabinoids work in the brain. Science 291:2530-2531.
2. Boghosian-Sell L, Comings DE, Overhauser J. 1996. Tourette syndrome in a pedigree with a 7;18 translocation: Identification of a YAC spanning the translocation breakpoint at 18q22.3. Am J Hum Genet 59:999-1005.
3. Comings DE. 2001. Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders. Ann NY Acad Sci 931:50-83.
4. Comings DE, Muhleman D, Gade R, Johnson P, Verde R, Saucier G, MacMurray J. 1997. Cannabinoid receptor gene (CNR1): Association with IV drug use. Mol Psychiatry 2:161-168.
5. Conne B, Stutz A, Vassalli JD. 2000. The 3′ untranslated region of messenger RNA: A molecular 'hotspot' for pathology? Nat Med 6:637-641.
6. Dawson E. 1995. Identification of a polymorphic triplet repeat marker for the brain cannabinoid receptor gene: Use in linkage and association studies of schizophrenia. Psychiatr Genet 5:S50.
7. Erdmann J, Shimron-Abarbanell D, Cichon S, Albus M, Maier W, Lichtermann D, Minges J, Reuner U, Franzek E, Ertl MA, et al. 1995. Systematic screening for mutations in the promoter and the coding region of the 5-HT1A gene. Am J Med Genet 60:393-399.
8. Gadzicki D, Müller-Vahl K, Stuhrmann M. 1999. A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene. Mol Cell Probes 13:321-323.
9. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, Bouaboula M, Shire D, Le Fur G, Casellas P. 1995. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54-61.
10. Gerard CM, Mollereau C, Vassart G, Parmentier M. 1990. Nucleotide sequence of a human cannabinoid receptor cDNA. Nucleic Acids Res 18:7142.
11. Hemming M, Yellowlees PM. 1993. Effective treatment of Tourette's syndrome with marijuana. J Psychopharmacol 7:389-391.
12. Leckman JF. 2002. Tourette's syndrome. Lancet 360:1577-1586.
13. Mailleux P, Vanderhaeghen JJ. 1992. Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48:655-668.
14. Merette C, Brassard A, Potvin A, Bouvier H, Rousseau F, Emond C, Bissonnette L, Roy MA, Maziade M, Ott J, Caron C. 2000. Significant linkage for Tourette syndrome in a large French Canadian family. Am J Hum Genet 67:1008-1013.
15. Müller-Vahl KR, Kolbe H, Schneider U, Emrich HM. 1998. Cannabinoids: Possible role in patho-physiology and therapy of Gilles de la Tourette syndrome. Acta Psychiatr Scand 98:502-506.
16. 9-tetrahydrocannabinol (THC). Pharmacopsychiatry 35:57-61.
17. 9-Tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette-syndrome: A 6-week randomized trial. J Clin Psychiatry 64:459-465.
18. Pauls DL. 2001. The genetics of Tourette syndrome. Curr Psychiatry Rep 3:152-157.
19. Petek E, Windpassinger C, Vincent JB, Cheung J, Boright AP, Scherer SW, Kroisel PM, Wagner K. 2001. Disruption of a novel gene (IMMP2L) by a breakpoint in 7q31 associated with Tourette syndrome. Am J Hum Genet 68:848-858.
20. Sandyk R, Awerbuch G. 1988. Marijuana and Tourette's syndrome. J Clin Psychopharmacol 8:444-445.
21. Shapiro AK, Shapiro ES, Young JG, Feinberg TE. 1988. Signs, symptoms, and clinical course. In: Shapiro AK, Shapiro ES, Young JG, Feinberg TE, editors. Gilles de la Tourette syndrome, New York: Raven Press. Vol 2. pp 127-193.
22. Shire D, Carillon C, Kaghad M, Calandra B, Rinaldi-Carmona M, Le Fur G, Caput D, Ferrara P. 1995. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J Biol Chem 270:3726-3731.
23. Simonic I, Nyholt DR, Gericke GS, Gordon D, Matsumoto N, Ledbetter DH, Ott J, Weber JL. 2001. Further evidence for linkage of Gilles de la Tourette syndrome (GTS) susceptibility loci on chromosomes 2p11, 8q22 and 11q23-24 in South African afrikaners. Am J Med Genet 105:163-167.
24. Stöber G, Hebebrand J, Cichon S, Brüss M, Bönisch H, Lehmkuhl G, Proustka F, Schmidt M, Remschmidt H, Propping P, Nöthen M. 1999. Tourette syndrome and the norepinephrine transporter gene: Results of a systematic mutation screening. Am J Med Genet 88:158-163.
25. The Tourette Syndrome Association International Consortium for Genetics. 1999. A complete genome screen in sib pairs affected by Gilles de la Tourette syndrome. Am J Hum Genet 65:1428-1436.
26. Verkerk AJ, Mathews CA, Joosse M, Eussen BH, Heutink P, Oostra BA. 2003. CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder. Genomics 82:1-9.
27. Zhang MQ. 1998. Statistical features of human exons and their flanking regions. Hum Mol Genet 7:919-932.
28. Zhang H, Leckman JF, Pauls DL, Tsai C-P, Kidd KK, Campos MR, the Tourette Syndrome Association International Consortium for Genetics. 2002. Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. Am J Hum Genet 70:896-904.